Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review

Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review

Abstract Background Prescribing pharmacologic therapies for critically ill patients requires a careful balancing of risks and benefits. Defining, monitoring, and reporting harms that occur in clinical trials conducted in critically ill populations, however, is challenging given that the natural hist...

Full description

Bibliographic Details
Main Authors: Ari Moskowitz, Lars W. Andersen, Mathias J. Holmberg, Anne V. Grossestreuer, Katherine M. Berg, Asger Granfeldt
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Critical Care
Subjects:
Clinical trial
Adverse event
Harm
CONSORT
Online Access:http://link.springer.com/article/10.1186/s13054-020-03113-z

Internet

http://link.springer.com/article/10.1186/s13054-020-03113-z

Similar Items